✦ LIBER ✦

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

✍ Scribed by Hong Suk Song; Young Rok Do; Heung Moon Chang; Min Hee Ryu; Kyung Hee Lee; Yeul Hong Kim; Dae Sik Hong; Jae Yong Cho; Kyoung Eun Lee; Si Young Kim

Publisher: Springer
Year: 2008
Tongue: English
Weight: 271 KB
Volume: 62
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-007-0661-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of gemcitabine plus cap

A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma

✍ Byeong-Bae Park; Joon Oh Park; Hyo Rak Lee; Jeeyun Lee; Dong Wook Choi; Seong-Ho 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 243 KB

Bevacizumab plus gemcitabine and oxalipl

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial

✍ David Fogelman; Mehrdad Jafari; Gauri R. Varadhachary; Henry Xiong; Susie Bulloc 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB

Phase II trial of S-1 in combination wit

Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer

✍ Gyeong-Won Lee; Hye Jung Kim; Ji-Hyun Ju; Seok-Hyun Kim; Hoon Gu Kim; Tae Hyo Ki 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 305 KB

Docetaxel plus gemcitabine in combinatio

Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study

✍ N. Xenidis; L. Chelis; K. Amarantidis; E. Chamalidou; P. Dimopoulos; N. Courcout 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 288 KB

A phase II study of neoadjuvant bevacizu

A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer

✍ Giampietro Gasparini; Francesco Torino; Takayuki Ueno; Stefano Cascinu; Teresa T 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 305 KB

A phase II study of bevacizumab plus erl

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer

✍ Andrew H. Ko; Alan P. Venook; Emily K. Bergsland; R. Kate Kelley; W. Michael Kor 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 266 KB